GlassScriptPhysician profile
Meredith Perry Jankowski
NPI 1063604239
$1,910.24
in general payments reported to CMS, 2019-2025
24 companies · $305 in 2025
The $305 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $47.36 · 2022: $229 · 2023: $223 · 2024: $862 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,390.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $682.55 | 2022-2025 | Interstim |
| Calyxo, INC. | $174.93 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $162.24 | 2024 | Axonics, Bulkamid |
| Palette Life Sciences, INC. | $128.10 | 2022 | |
| Karl Storz Endoscopy-America | $108.75 | 2024 | Image1 S Connect |
| Coloplast Corp | $100.99 | 2019 | |
| Bluewind Medical | $98.11 | 2024 | Revi |
| Neotract INC. | $62.91 | 2019 | |
| Astellas Pharma US INC | $51.99 | 2019 | |
| Stemline Therapeutics INC. | $48.76 | 2023-2024 | Orserdu |
| Bayer Healthcare Pharmaceuticals INC. | $36.66 | 2020-2024 | |
| Bioprotect Medical, INC. | $27.75 | 2025 | Bioprotect Balloon Implant System |
| Teleflex LLC | $27.58 | 2025 | Barrigel |
| Boston Scientific Corporation | $27.50 | 2019 | |
| Kci USA, INC. | $23.12 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Puma Biotechnology, INC. | $22.81 | 2025 | |
| Tersera Therapeutics LLC | $20.66 | 2025 | Zoladex |
| Srs Medical Systems, INC. | $19.84 | 2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Lilly USA, LLC | $16.44 | 2024 | Omvoh |
| Seagen INC. | $15.75 | 2023 | Tukysa |
| Incyte Corporation | $15.58 | 2022 | |
| Janssen Biotech, INC. | $14.92 | 2024 | Tecvayli |
| Sumitomo Pharma America, INC. | $14.34 | 2024 | Orgovyx |
| Ambu INC. | $7.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Jankowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.